Evidence map›Paper›PMID 41025688›Full record

ArticleAllergy2026

Extracellular Vesicle miRNAs as Biomarkers of Asthma Severity.

Chandrashekhar Prasad, Rachel Griffard, Dong Pei, Steven Haworth, Navneet K Dhillon, Mario Castro, Isaac Kirubakaran Sundar

Abstract readLetter
In one paragraph

Article in Allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chandrashekhar PrasadDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Kansas City, Kansas, USA.
Rachel GriffardDepartment of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID https://orcid.org/0000-0002-3330-695X
Dong PeiDepartment of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID https://orcid.org/0000-0002-8367-729X
Steven HaworthDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Kansas City, Kansas, USA.
Navneet K DhillonDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Kansas City, Kansas, USA.ORCID https://orcid.org/0000-0001-6582-5757
Mario CastroDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Kansas City, Kansas, USA.ORCID https://orcid.org/0000-0001-6328-8994
Isaac Kirubakaran SundarDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Kansas City, Kansas, USA.ORCID https://orcid.org/0000-0001-6742-3460

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ANDREW K. GODWIN · 2019 to 2026
$21.5M
Rapid saliva antigen test for SARS-CoV-2 detectionU01HL146002 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ARONICA, MARK A, CASTRO, MARIO · 2019 to 2023
$17.3M
Using PCORnet to Expand the DS-CONNECT Cohort Through Healthcare System Recruitment, Incorporating Electronic Health Records, and Assessing Self-DeterminationU54HD090216 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI COLOMBO, JOHN A. · 2016 to 2020
$6.2M
Molecular Regulation of Cell Development and Differentiation Phase III COBREP30GM122731 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI VIVIAN, JAY L · 2017 to 2021
$5.6M
Severe Asthma Research Program (SARP)-Washington UniversityU10HL109257 · NHLBI · WASHINGTON UNIVERSITY · PI CASTRO, MARIO · 2011 to 2016
$3.8M
Nuclear Receptor REV-ERB alpha Role in the Pathophysiology of Allergic AsthmaR01HL142543 · NHLBI · UNIVERSITY OF ROCHESTER · PI SUNDAR, ISAAC KIRUBAKARAN · 2019 to 2023
$1.9M
NovaSeq X Plus Sequencing SystemS10OD036343 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SMITH, PETER G · 2024 to 2024
$1.1M
Lied Pre-clinical Grant-FY 2024NCATS NIH HHS UL1 TR002366NCI NIH HHS P30 CA168524NHLBI NIH HHS R01 HL142543NHLBI NIH HHS U01 HL146002NHLBI NIH HHS U10 HL109257NICHD NIH HHS U54 HD090216NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM130423NIGMS NIH HHS P30 GM122731NIH HHS S10 OD036343ODCDC CDC HHS S10 OD036343University of Kansas Medical Center, School of Medicine, Internal Medicine Start-Up Funds
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41025688
PMCPMC13085337

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.